Aflatoxin B1

Last updated

Contents

Aflatoxin B1
(-)-Aflatoxin B1 Structural Formulae V.1.svg
Chemical structure of (−)-aflatoxin B1
Aflatoxin-B1-from-xtal-3D-bs-17.png
Ball-and-stick model of aflatoxin B1 [1] [2]
Names
Preferred IUPAC name
(6aR,9aS)-4-Methoxy-2,3,6a,9a-tetrahydrocyclopenta[c]furo[3′,2′:4,5]furo[2,3-h][1]benzopyran-1,11-dione
Other names
NSC 529592
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
ECHA InfoCard 100.013.276 OOjs UI icon edit-ltr-progressive.svg
PubChem CID
UNII
  • InChI=1S/C17H12O6/c1-20-10-6-11-14(8-4-5-21-17(8)22-11)15-13(10)7-2-3-9(18)12(7)16(19)23-15/h4-6,8,17H,2-3H2,1H3 Yes check.svgY
    Key: OQIQSTLJSLGHID-UHFFFAOYSA-N Yes check.svgY
  • O=C5C=4C(=O)Oc3c1c(OC2O\C=C/C12)cc(OC)c3C=4CC5
Properties
C17H12O6
Molar mass 312.277 g·mol−1
Hazards
Occupational safety and health (OHS/OSH):
Main hazards
CarcinogenMutagenAcute toxicity / Poison [3]
GHS labelling:
GHS-pictogram-skull.svg GHS-pictogram-silhouette.svg
Danger
H300, H310, H330, H340, H350
P201, P202, P260, P262, P264, P270, P271, P280, P281, P284, P301+P330+P331, P302+P350, P304+P340, P308+P313, P310, P311, P320, P321, P322, P330, P361, P363, P403+P233, P405, P501
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
X mark.svgN  verify  (what is  Yes check.svgYX mark.svgN ?)

Aflatoxin B1 is an aflatoxin produced by Aspergillus flavus and A. parasiticus . It is a very potent carcinogen with a TD50 3.2 μg/kg/day in rats. [4] This carcinogenic potency varies across species with some, such as rats and monkeys, seemingly much more susceptible than others. [5] [6] Aflatoxin B1 is a common contaminant in a variety of foods including peanuts, cottonseed meal, corn, and other grains; [7] as well as animal feeds. [8] Aflatoxin B1 is considered the most toxic aflatoxin and it is highly implicated in hepatocellular carcinoma (HCC) in humans. [9] In animals, aflatoxin B1 has also been shown to be mutagenic, [10] teratogenic, [11] and to cause immunosuppression. [12] Several sampling and analytical methods including thin-layer chromatography (TLC), high-performance liquid chromatography (HPLC), mass spectrometry, and enzyme-linked immunosorbent assay (ELISA), among others, have been used to test for aflatoxin B1 contamination in foods. [13] According to the Food and Agriculture Organization (FAO), a division of the United Nations, the worldwide maximum tolerated levels of aflatoxin B1 was reported to be in the range of 1–20 μg/kg (or .001 ppm - 1 part-per-billion) in food, and 5–50 μg/kg (.005 ppm) in dietary cattle feed in 2003. [14]

Sources of exposure

Aflatoxin B1 is mostly found in contaminated food and humans are exposed to aflatoxin B1 almost entirely through their diet. [15] Occupational exposure to aflatoxin B1 has also been reported in swine [16] and poultry production. [17] While aflatoxin B1 contamination is common in many staple foods, its production is maximized in foods stored in hot, humid climates. [18] Exposure is therefore most common in Southeast Asia, South America, and Sub-Saharan Africa. [18]

Pathology

Aflatoxin B1 can permeate through the skin. Dermal exposure to this aflatoxin in particular environmental conditions can lead to major health risks. [19] The liver is the most susceptible organ to aflatoxin B1 toxicity. In animal studies, pathological lesions associated with aflatoxin B1 intoxication include reduction in weight of liver, [20] vacuolation of hepatocytes, [21] and hepatic carcinoma. [22] Other liver lesions include enlargement of hepatic cells, fatty infiltration, necrosis, hemorrhage, fibrosis, regeneration of nodules, and bile duct proliferation/hyperplasia. [23]

Aspergillus flavus

Aspergillus flavus is a fungus of the family Trichocomaceae with a worldwide distribution. The mold lives in soil, surviving off dead plant and animal matter, but spreads through the air via airborne conidia. [24] This fungus grows in long branched hyphae and is capable of surviving on numerous food sources including corn and peanuts. [25] The fungus and its products are pathogenic to a number of species, including humans. [24] While toxicity of its products, aflatoxins, are explored throughout this article, Aspergillus flavus itself also exerts pathogenic effects through aspergillosis, or infection with the mold. This infection largely occurs in the lungs of immune compromised patients but infection may also occur in the skin or other organs. [26] Unlike many mold species, Aspergillus flavus prefers hot and dry conditions. Its optimal growth at 37 °C (99 °F) contributes to its pathogenicity in humans. [24]

Biosynthetic pathway

Aflatoxin B1 is derived from both a dedicated fatty acid synthase (FAS) and a polyketide synthase (PKS), together known as norsolorinic acid synthase. The biosynthesis begins with the synthesis of hexanoate by the FAS, which then becomes the starter unit for the iterative type I PKS. [27] [28] [29] The PKS adds seven malonyl-CoA extenders to the hexanoate to form the C20 polyketide compound. The PKS folds the polyketide in a particular way to induce cyclization to form the anthraquinone norsolorinic acid. A reductase then catalyzes the reduction of the ketone on the norsolorinic acid side-chain to yield averantin. [27] [28] [29] Averantin is converted to averufin via a two different enzymes, a hydroxylase and an alcohol dehydrogenase. This will oxygenate and cyclize averantin's side chain to form the ketal in averufin.

From this point on the biosynthetic pathway of aflatoxin B1 becomes much more complicated, with several major skeletal changes. Most of the enzymes have not been characterized and there may be several more intermediates that are still unknown. [27] However, what is known is that averufin is oxidized by a P450-oxidase, AvfA, in a Baeyer-Villiger oxidation. This opens the ether rings and upon rearrangement versiconal acetate is formed. Now an esterase, EstA, catalyzes the hydrolysis of the acetyl, forming the primary alcohol in versiconal. [27] [29] The acetal in versicolorin A is formed from the cyclization of the side-chain in versiconal, which is catalyzed by VERB synthase, and then VerB, a desaturase, reduces versicolorin B to form the dihydrobisfuran. [27] [29]

There are two more enzymes that catalyze the conversion of versicolorin A to demethylsterigmatocystin: AflN, an oxidase and AflM, a reductase. These enzymes use both molecular oxygen and two NADPH's to dehydrate one of the hydroxyl groups on the anthraquinone and open the quinine with the molecular oxygen. [27] [29] Upon forming the aldehyde in the ring opening step, it is oxidized to form the carboxylic acid and subsequently a decarboxylation event occurs to close the ring, forming the six-member ether ring system seen in demethylsterigmatocystin. The next two steps in the biosynthetic pathway is the methylation by S-adenosyl methionine (SAM) of the two hydroxyl groups on the xanthone part of demethysterigmatocystin by two different methyltransferases, OmtB and OmtA. [27] [29] This yields O-methylsterigmatocystin. In the final steps there is an oxidative cleavage of the aromatic ring and loss of one carbon in O-methylsterigmatocystin, which is catalyzed by OrdA, an oxidoreductase. [27] [29] Then a final recyclization occurs to form aflatoxin B1.

Mechanism of carcinogenicity

Aflatoxin B1 is a potent genotoxic hepatocarcinogen with its exposure strongly linked to the development of hepatocellular carcinoma, liver tumors, especially given co-infection with hepatitis B virus. [18] These effects seem to be largely mediated by mutations at guanine in codon 249 of the p53 gene, a tumor suppressing gene, [30] and at several guanine residues in the 12th and 13th codons of the ras gene, a gene whose product controls cellular proliferation signals. [31] [32] Aflatoxin B1 must first be metabolized into its reactive electrophilic form, aflatoxin B1-8,9-exo-epoxide by cytochrome p450. [18] This active form then intercalates between DNA base residues and forms adducts with guanine residues, most commonly aflatoxin B1-N7-Gua. These adducts may then rearrange or become removed from the backbone altogether, forming an apurinic site. These adducts and alterations represent lesions which, upon DNA replication cause the insertion of a mis-matched base in the opposing strand. Up to 44% of hepatocellular carcinomas in regions with high aflatoxin exposure bear a GC → TA transversion at codon 249 of p53, a characteristic mutation seen with this toxin. [32]

Adapted from Semela et al. 2001 Aflatoxin B1 DNA Adduct Formation.png
Adapted from Semela et al. 2001

Prevalence of hepatocellular carcinoma in individuals exposed to aflatoxin, increases with co-infection of hepatitis B virus. One study estimated that while individuals with urinary aflatoxin bio-markers were at a threefold greater risk than the normal population for hepatocellular carcinoma; those infected with hepatitis B virus were at a fourfold risk; and those with the aflatoxin bio-markers and infected with hepatitis B virus were at a 60 times greater risk for hepatocellular carcinoma than the normal population. [33] [32]

Toxicity

Several aflatoxin B1 toxicity studies have been conducted on various animal species. [34]

Acute toxicity
The oral LD50 range of aflatoxin B1 is estimated to be 0.3–17.9 mg/kg body weight for most animal species. [35] For instance, the oral LD50 of aflatoxin B1 is estimated to be 17.9 mg/kg body weight in female rats and 7.2 mg/kg body weight in male rats. Still in male rats, the intraperitoneal LD50 of aflatoxin B1 is estimated to be 6.0 mg/kg body weight. [36] Symptoms include anorexia, malaise, and low-grade fever. [37]
Subacute toxicity
Subacute toxicity studies of aflatoxin B1 in animals showed moderate to severe liver damage. In monkeys for instance, subacute toxicity studies showed portal inflammation and fatty change. [38]
Chronic toxicity
Chronic toxicity studies of aflatoxin B1 in chickens showed decreased hepatic microsomal cytochrome P-450 concentration, reduction in feed consumption and decreased weight gain. [39]
Subchronic toxicity
Subchronic toxicity studies of aflatoxin B1 in fish showed fish to present with preneoplastic lesions, concurrently with changes in gill, pancreas, intestine and spleen. [40]
Genotoxicity
Treatment of human liver cells with aflatoxin B1 at doses that ranged from 3–5 μmol/L resulted in the formation of aflatoxin B1-DNA adducts, 8-hydroxyguanine lesions and DNA damage. [41]
Carcinogenicity
The carcinogenicity of aflatoxin B1, which is characterized by the development of liver cell carcinoma, has been reported in rat studies. [42]
Embryotoxicity
Embryonic death and impaired embryonic development of the bursa of Fabricius in chickens by aflatoxin B1 has been reported. [43]
Teratogenicity
The teratogenic effects of aflatoxin B1 in rabbits have been reported to include reduced fetal weights, wrist drop, enlarged eye socket, agenesis of caudal vertebrae, micropthalmia, cardiac defects, and lenticular degeneration, among others. [44]
Immunotoxicity
Studies in fish showed aflatoxin B1 to have significant immunosuppressive effects including reduced serum total globulin and reduced bactericidal activities. [45]

Risk management and regulations

Aflatoxin B1 exposure is best managed by measures aimed at preventing contamination of crops in the field, post-harvest handling, and storage, or via measures aimed at detecting and decontaminating contaminated commodities or materials used in animal feed. For instance, biological decontamination involving the use of a single bacterial species, Flavobacterium aurantiacum has been used to remove aflatoxin B1 from peanuts and corn. [46]

Several countries around the world have rules and regulations governing aflatoxin B1 in foods and these include the maximum permitted, or recommended levels of aflatoxin B1 for certain foods. [47]

United States (US)
US food safety regulations have set a maximum permitted level of 20 μg/kg for aflatoxin B1, in combination with the other aflatoxins (B2, G1 and G2) in all foods, with the exception of milk which has a maximum permitted level of 0.5 μg/kg. Higher levels of 100–300 μg/kg are tolerable for some animal feeds. [48] [49]
European Union (EU)
The EU has set maximum permitted levels for aflatoxin B1 in nuts, dried fruits, cereals and spices to range from 2–12 μg/kg, while the maximum permitted level for aflatoxin B1 in infant foods is set at 0.1 μg/kg. [46] The maximum permitted levels for aflatoxin B1 in animal feeds set by the EU range from 5–50 μg/kg and these levels are much lower than those set in the US. [50]
Joint United Nations' Food and Agriculture Organization (FAO)/World Health Organization (WHO) Expert Committee on Food Additives (JECFA)
The FAO/WHO JECFA has set the maximum permitted levels of aflatoxin B1 in combination with the other aflatoxins (B2, G1 and G2) to be 15 μg/kg in raw peanuts and 10 μg/kg in processeds peanut; while the tolerance level of aflatoxin B1 alone is 5 μg/kg for dairy cattle feed. [51] [52]

Notable exposures

The discovery of aflatoxin B1 came on the heels of the widespread death of turkeys in England in the summer of 1960 to some unknown disease, at the time labeled "Disease X". Over the course of 500 outbreaks, the disease claimed over 100,000 turkeys which appeared to be healthy. The widespread death was later found to be caused by Aspergillus flavus contamination of peanut meal. [53] [54]

Twelve patients died of acute aflatoxin poisoning in several hospitals in the Machakos district of Kenya in 1981 following the consumption of contaminated maize. All patients also suffered from hepatitis. [55]

Following outbreaks of aflatoxin contamination in maize reaching 4,400 ppb in the spring of 2004, 125 individuals in Kenya died of acute hepatic failure while some 317 cases in total were reported. To date this was the largest known outbreak of aflatoxicosis in terms of fatalities documented. [37]

Related Research Articles

<span class="mw-page-title-main">Mold health issues</span> Harmful effects of molds

Mold health issues refer to the harmful health effects of molds and their mycotoxins.

<span class="mw-page-title-main">Copra</span> Dried meat or kernel of the coconut

Copra is the dried, white flesh of the coconut from which coconut oil is extracted. Traditionally, the coconuts are sun-dried, especially for export, before the oil, also known as copra oil, is pressed out. The oil extracted from copra is rich in lauric acid, making it an important commodity in the preparation of lauryl alcohol, soaps, fatty acids, cosmetics, etc. and thus a lucrative product for many coconut-producing countries. The palatable oil cake, known as copra cake, obtained as a residue in the production of copra oil is used in animal feeds. The ground cake is known as coconut or copra meal.

<span class="mw-page-title-main">Aflatoxin</span> Group of poisons produced by moulds

Aflatoxins are various poisonous carcinogens and mutagens that are produced by certain molds, particularly Aspergillus species mainly by Aspergillus flavus and Aspergillus parasiticus. According to the USDA, "They are probably the best known and most intensively researched mycotoxins in the world." The fungi grow in soil, decaying vegetation and various staple foodstuffs and commodities such as hay, maize, peanuts, coffee, wheat, millet, sorghum, cassava, rice, chili peppers, cottonseed, tree nuts, sesame seeds, sunflower seeds, and various cereal grains and oil seeds. In short, the relevant fungi grow on almost any crop or food. When such contaminated food is processed or consumed, the aflatoxins enter the general food supply. They have been found in both pet and human foods, as well as in feedstocks for agricultural animals. Animals fed contaminated food can pass aflatoxin transformation products into milk, milk products, and meat. For example, contaminated poultry feed is the suspected source of aflatoxin-contaminated chicken meat and eggs in Pakistan.

<span class="mw-page-title-main">Hepatocellular carcinoma</span> Medical condition

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer in adults and is currently the most common cause of death in people with cirrhosis. HCC is the third leading cause of cancer-related deaths worldwide.

<span class="mw-page-title-main">Foodborne illness</span> Illness from eating spoiled food

Foodborne illness is any illness resulting from the contamination of food by pathogenic bacteria, viruses, or parasites, as well as prions, and toxins such as aflatoxins in peanuts, poisonous mushrooms, and various species of beans that have not been boiled for at least 10 minutes.

A mycotoxin is a toxic secondary metabolite produced by fungi and is capable of causing disease and death in both humans and other animals. The term 'mycotoxin' is usually reserved for the toxic chemical products produced by fungi that readily colonize crops.

<i>Aspergillus flavus</i> Species of fungus

Aspergillus flavus is a saprotrophic and pathogenic fungus with a cosmopolitan distribution. It is best known for its colonization of cereal grains, legumes, and tree nuts. Postharvest rot typically develops during harvest, storage, and/or transit. Its specific name flavus derives from the Latin meaning yellow, a reference to the frequently observed colour of the spores. A. flavus infections can occur while hosts are still in the field (preharvest), but often show no symptoms (dormancy) until postharvest storage or transport.

<span class="mw-page-title-main">Fumonisin B1</span> Chemical compound

Fumonisin B1 is the most prevalent member of a family of toxins, known as fumonisins, produced by multiple species of Fusarium molds, such as Fusarium verticillioides, which occur mainly in maize (corn), wheat and other cereals. Fumonisin B1 contamination of maize has been reported worldwide at mg/kg levels. Human exposure occurs at levels of micrograms to milligrams per day and is greatest in regions where maize products are the dietary staple.

<span class="mw-page-title-main">Trichothecene</span> Large family of chemically related mycotoxins

Trichothecenes constitute a large group of chemically related mycotoxins. They are produced by fungi of the genera Fusarium, Myrothecium, Trichoderma, Podostroma, Trichothecium, Cephalosporium, Verticimonosporium, Stachybotrys and possibly others. Chemically, trichothecenes are a class of sesquiterpenes.

<span class="mw-page-title-main">Ochratoxin A</span> Chemical compound

Ochratoxin A—a toxin produced by different Aspergillus and Penicillium species — is one of the most-abundant food-contaminating mycotoxins. It is also a frequent contaminant of water-damaged houses and of heating ducts. Human exposure can occur through consumption of contaminated food products, particularly contaminated grain and pork products, as well as coffee, wine grapes, and dried grapes. The toxin has been found in the tissues and organs of animals, including human blood and breast milk. Ochratoxin A, like most toxic substances, has large species- and sex-specific toxicological differences.

<span class="mw-page-title-main">Citrinin</span> Chemical compound

Citrinin is a mycotoxin which is often found in food. It is a secondary metabolite produced by fungi that contaminates long-stored food and it can cause a variety of toxic effects, including kidney, liver and cell damage. Citrinin is mainly found in stored grains, but sometimes also in fruits and other plant products.

Patulin is an organic compound classified as a polyketide. It is named after the fungus from which it was isolated, Penicillium patulum. It is a white powder soluble in acidic water and in organic solvents. It is a lactone that is heat-stable, so it is not destroyed by pasteurization or thermal denaturation. However, stability following fermentation is lessened. It is a mycotoxin produced by a variety of molds, in particular, Aspergillus and Penicillium and Byssochlamys. Most commonly found in rotting apples, the amount of patulin in apple products is generally viewed as a measure of the quality of the apples used in production. In addition, patulin has been found in other foods such as grains, fruits, and vegetables. Its presence is highly regulated.

Mycotoxicology is the branch of mycology that focuses on analyzing and studying the toxins produced by fungi, known as mycotoxins. In the food industry it is important to adopt measures that keep mycotoxin levels as low as practicable, especially those that are heat-stable. These chemical compounds are the result of secondary metabolism initiated in response to specific developmental or environmental signals. This includes biological stress from the environment, such as lower nutrients or competition for those available. Under this secondary path the fungus produces a wide array of compounds in order to gain some level of advantage, such as incrementing the efficiency of metabolic processes to gain more energy from less food, or attacking other microorganisms and being able to use their remains as a food source.

<span class="mw-page-title-main">Sterigmatocystin</span> Chemical compound

Sterigmatocystin is a polyketide mycotoxin produced by certain species of Aspergillus. The toxin is naturally found in some cheeses.

<span class="mw-page-title-main">Liver cancer</span> Medical condition

Liver cancer, also known as hepatic cancer, primary hepatic cancer, or primary hepatic malignancy, is cancer that starts in the liver. Liver cancer can be primary in which the cancer starts in the liver, or it can be liver metastasis, or secondary, in which the cancer spreads from elsewhere in the body to the liver. Liver metastasis is the more common of the two liver cancers. Instances of liver cancer are increasing globally.

Mycotoxins are secondary metabolites produced by filamentous fungi, commonly detected as contaminants in agricultural commodities globally. Exposure to these toxins can be very detrimental to both humans and animal, and can lead to mycotoxicosis, which can be a variety of medical conditions. In animals, exposure through feed can disrupt nutrient digestion, absorption, metabolism, and even affect animal physiology. The most common fungi that produce mycotoxins include Fusarium, Aspergillus, and Penicillium.

Aspergillus ochraceus is a mold species in the genus Aspergillus known to produce the toxin ochratoxin A, one of the most abundant food-contaminating mycotoxins, and citrinin. It also produces the dihydroisocoumarin mellein. It is a filamentous fungus in nature and has characteristic biseriate conidiophores. Traditionally a soil fungus, has now began to adapt to varied ecological niches, like agricultural commodities, farmed animal and marine species. In humans and animals the consumption of this fungus produces chronic neurotoxic, immunosuppressive, genotoxic, carcinogenic and teratogenic effects. Its airborne spores are one of the potential causes of asthma in children and lung diseases in humans. The pig and chicken populations in the farms are the most affected by this fungus and its mycotoxins. Certain fungicides like mancozeb, copper oxychloride, and sulfur have inhibitory effects on the growth of this fungus and its mycotoxin producing capacities.

<i>Aspergillus parasiticus</i> Species of fungus

Aspergillus parasiticus is a fungus belonging to the genus Aspergillus. This species is an unspecialized saprophytic mold, mostly found outdoors in areas of rich soil with decaying plant material as well as in dry grain storage facilities. Often confused with the closely related species, A. flavus, A. parasiticus has defined morphological and molecular differences. Aspergillus parasiticus is one of three fungi able to produce the mycotoxin, aflatoxin, one of the most carcinogenic naturally occurring substances. Environmental stress can upregulate aflatoxin production by the fungus, which can occur when the fungus is growing on plants that become damaged due to exposure to poor weather conditions, during drought, by insects, or by birds. In humans, exposure to A. parasiticus toxins can cause delayed development in children and produce serious liver diseases and/or hepatic carcinoma in adults. The fungus can also cause the infection known as aspergillosis in humans and other animals. A. parasiticus is of agricultural importance due to its ability to cause disease in corn, peanut, and cottonseed.

<span class="mw-page-title-main">Nivalenol</span> Type of mycotoxin

Nivalenol (NIV) is a mycotoxin of the trichothecene group. In nature it is mainly found in fungi of the Fusarium species. The Fusarium species belongs to the most prevalent mycotoxin producing fungi in the temperate regions of the northern hemisphere, therefore making them a considerable risk for the food crop production industry.

Aflatoxin M<sub>1</sub> Chemical compound

Aflatoxin M1 is a chemical compound of the aflatoxin class, a group of mycotoxins produced by three species of AspergillusAspergillus flavus, Aspergillus parasiticus, and the rare Aspergillus nomius – which contaminate plant and plant products.

References

  1. "AFLATC: Aflatoxin B1 chloroform solvate". Cambridge Structural Database: Access Structures. Cambridge Crystallographic Data Centre . Retrieved 2021-03-23.
  2. van Soest TC, Peerdeman AF (1970). "The crystal structures of aflatoxin B1. I. The structure of the chloroform solvate of aflatoxin B1 and the absolute configuration of aflatoxin B1". Acta Crystallogr. B . 26 (12): 1940–1947. Bibcode:1970AcCrB..26.1940V. doi:10.1107/S0567740870005228.
  3. "Aflatoxin B1". PubChem. U.S. National Library of Medicine.
  4. "Summary Table by Chemical of Carcinogenicity Results in CPDB on 1547 Chemicals" (PDF). Toxnet.
  5. McLean M, Dutton MF (February 1995). "Cellular interactions and metabolism of aflatoxin: an update". Pharmacology & Therapeutics. 65 (2): 163–192. doi:10.1016/0163-7258(94)00054-7. PMID   7540767.
  6. "Aflatoxin B1 (CAS 1162-65-8)". The Carcinogenic Potency Project.
  7. Galvano F, Ritieni A, Piva G, Pietri A (2005). "Mycotoxins in the human food chain.". In Diaz DE (ed.). The Mycotoxin Blue Book. Nottingham, UK: Nottingham University Press. pp. 187–224.
  8. Azab RM, Tawakkol WM, Hamad AM, Abou-Elmagd MK, El-Agrab HM, Refai MK (2005). "Detection and estimation of aflatoxin B1 in feeds and its biodegradation by bacteria and fungi". Egyptian Journal of Natural Toxins. 2: 39–56.
  9. Chen T, Liu J, Li Y, Wei S (February 2022). "Burden of Disease Associated with Dietary Exposure to Aflatoxins in China in 2020". Nutrients. 14 (5): 1027. doi: 10.3390/nu14051027 . PMC   8912679 . PMID   35268003.
  10. Chen T, Heflich RH, Moore MM, Mei N (March 2010). "Differential mutagenicity of aflatoxin B1 in the liver of neonatal and adult mice". Environmental and Molecular Mutagenesis. 51 (2): 156–163. Bibcode:2010EnvMM..51..156C. doi:10.1002/em.20518. PMC   6359889 . PMID   19642212.
  11. Geissler F, Faustman EM (February 1988). "Developmental toxicity of aflatoxin B1 in the rodent embryo in vitro: contribution of exogenous biotransformation systems to toxicity". Teratology. 37 (2): 101–111. doi:10.1002/tera.1420370203. PMID   3127910.
  12. Meissonnier GM, Pinton P, Laffitte J, Cossalter AM, Gong YY, Wild CP, et al. (September 2008). "Immunotoxicity of aflatoxin B1: impairment of the cell-mediated response to vaccine antigen and modulation of cytokine expression". Toxicology and Applied Pharmacology. 231 (2): 142–149. Bibcode:2008ToxAP.231..142M. doi:10.1016/j.taap.2008.04.004. PMID   18501398.
  13. Wacoo AP, Wendiro D, Vuzi PC, Hawumba JF (2014). "Methods for Detection of Aflatoxins in Agricultural Food Crops". Journal of Applied Chemistry. 2014: 1–15. doi: 10.1155/2014/706291 .
  14. "Worldwide regulations for mycotoxins in food and feed in 2003". Food and Agricultural Organization. United Nations.
  15. Coulombe RA (March 1993). "Biological action of mycotoxins". Journal of Dairy Science. 76 (3): 880–891. doi: 10.3168/jds.s0022-0302(93)77414-7 . PMID   8463495.
  16. Viegas S, Veiga L, Figueredo P, Almeida A, Carolino E, Sabino R, et al. (2013). "Occupational exposure to aflatoxin B1 in swine production and possible contamination sources". Journal of Toxicology and Environmental Health. Part A. 76 (15): 944–951. Bibcode:2013JTEHA..76..944V. doi:10.1080/15287394.2013.826569. hdl: 10400.21/2889 . PMID   24156697. S2CID   36686813.
  17. Viegas S, Veiga L, Malta-Vacas J, Sabino R, Figueredo P, Almeida A, et al. (2012). "Occupational exposure to aflatoxin (AFB₁) in poultry production". Journal of Toxicology and Environmental Health. Part A. 75 (22–23): 1330–1340. Bibcode:2012JTEHA..75.1330V. doi:10.1080/15287394.2012.721164. hdl: 10400.21/1927 . PMID   23095151. S2CID   205866375.
  18. 1 2 3 4 Kew MC (September 2013). "Aflatoxins as a cause of hepatocellular carcinoma". Journal of Gastrointestinal and Liver Diseases. 22 (3): 305–310. PMID   24078988.
  19. Boonen J, Malysheva SV, Taevernier L, Diana Di Mavungu J, De Saeger S, De Spiegeleer B (November 2012). "Human skin penetration of selected model mycotoxins". Toxicology. 301 (1–3): 21–32. Bibcode:2012Toxgy.301...21B. doi:10.1016/j.tox.2012.06.012. PMID   22749975.
  20. Fernández A, Ramos JJ, Sanz M, Saez T, Fernández de Luco D (1996). "Alterations in the performance, haematology and clinical biochemistry of growing lambs fed with aflatoxin in the diet". Journal of Applied Toxicology. 16 (1): 85–91. doi:10.1002/(SICI)1099-1263(199601)16:1<85::AID-JAT315>3.0.CO;2-T. PMID   8821681.
  21. Espada Y, Domingo M, Gomez J, Calvo MA (November 1992). "Pathological lesions following an experimental intoxication with aflatoxin B1 in broiler chickens". Research in Veterinary Science. 53 (3): 275–9. doi:10.1016/0034-5288(92)90127-n. PMID   1465501.
  22. Larsson P, Busk L, Tjälve H (May 1994). "Hepatic and extrahepatic bioactivation and GSH conjugation of aflatoxin B1 in sheep". Carcinogenesis. 15 (5): 947–955. doi:10.1093/carcin/15.5.947. PMID   8200100.
  23. Patterson DS (1977). "Aflatoxin and related compounds: Introduction". In Wyllie TD, Morehouse LG (eds.). Mycotoxic Fungi, Mycotoxins, Mycotoxicoses, an Encyclopaedic Handbook. Vol. 1 (1st ed.). New York, NY, USA: Marcel Dekker Inc. pp. 131–135. ISBN   978-0-8247-6550-7.
  24. 1 2 3 Hedayati MT, Pasqualotto AC, Warn PA, Bowyer P, Denning DW (June 2007). "Aspergillus flavus: human pathogen, allergen and mycotoxin producer". Microbiology. 153 (Pt 6): 1677–1692. doi: 10.1099/mic.0.2007/007641-0 . PMID   17526826.
  25. "Aspergillus flavus :: Center for Integrated Fungal Research". www.cifr.ncsu.edu. Retrieved 2017-05-08.
  26. "Definition of Aspergillosis | Aspergillosis | Types of Fungal Diseases | Fungal Diseases | CDC". www.cdc.gov. Retrieved 2017-05-08.
  27. 1 2 3 4 5 6 7 8 Dewick PM (2009). Medicinal Natural Products: A Biosynthetic Approach (3rd ed.). Wiley. pp. 122–124. ISBN   978-0-470-74279-2.
  28. 1 2 Singh R, Hsieh DP (January 1977). "Aflatoxin biosynthetic pathway: elucidation by using blocked mutants of Aspergillus parasiticus". Archives of Biochemistry and Biophysics. 178 (1): 285–292. doi:10.1016/0003-9861(77)90193-x. PMID   836036.
  29. 1 2 3 4 5 6 7 Yu J, Chang PK, Ehrlich KC, Cary JW, Bhatnagar D, Cleveland TE, et al. (March 2004). "Clustered pathway genes in aflatoxin biosynthesis". Applied and Environmental Microbiology. 70 (3): 1253–1262. Bibcode:2004ApEnM..70.1253Y. doi:10.1128/AEM.70.3.1253-1262.2004. PMC   368384 . PMID   15006741.
  30. The p53 tumor suppressor protein. National Center for Biotechnology Information (US). January 1998.
  31. Fernández-Medarde A, Santos E (March 2011). "Ras in cancer and developmental diseases". Genes & Cancer. 2 (3): 344–358. doi:10.1177/1947601911411084. PMC   3128640 . PMID   21779504.
  32. 1 2 3 Smela ME, Currier SS, Bailey EA, Essigmann JM (April 2001). "The chemistry and biology of aflatoxin B(1): from mutational spectrometry to carcinogenesis". Carcinogenesis. 22 (4): 535–545. doi: 10.1093/carcin/22.4.535 . PMID   11285186.
  33. Ross RK, Yuan JM, Yu MC, Wogan GN, Qian GS, Tu JT, et al. (April 1992). "Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma". Lancet. 339 (8799): 943–946. doi:10.1016/0140-6736(92)91528-g. PMID   1348796. S2CID   30127032.
  34. Wogan GN (June 1966). "Chemical nature and biological effects of the aflatoxins". Bacteriological Reviews. 30 (2): 460–470. doi:10.1128/BR.30.2.460-470.1966. PMC   441006 . PMID   5327461.
  35. Agag BI (2004). "Mycotoxins in foods and feeds 1-Aflatoxins". Assiut University Bulletin for Environmental Researches. 7 (1): 173–205. doi:10.21608/auber.2004.150623.
  36. Butler WH (December 1964). "Acute Toxicity of Aflatoxin B1 in Rats". British Journal of Cancer. 18 (4): 756–762. doi:10.1038/bjc.1964.87. PMC   2071183 . PMID   14264941.
  37. 1 2 Azziz-Baumgartner E, Lindblade K, Gieseker K, Rogers HS, Kieszak S, Njapau H, et al. (December 2005). "Case-control study of an acute aflatoxicosis outbreak, Kenya, 2004". Environmental Health Perspectives. 113 (12): 1779–1783. doi:10.1289/ehp.8384. JSTOR   3436751. PMC   1314920 . PMID   16330363.
  38. Tulpule PG, Madhavan TV, Gopalan C (May 1964). "Effect of feeding aflatoxin to young monkeys". Lancet. 1 (7340): 962–963. doi:10.1016/s0140-6736(64)91748-9. PMID   14121357.
  39. Dalvi RR, McGowan C (March 1984). "Experimental induction of chronic aflatoxicosis in chickens by purified aflatoxin B1 and its reversal by activated charcoal, phenobarbital, and reduced glutathione". Poultry Science. 63 (3): 485–491. doi: 10.3382/ps.0630485 . PMID   6425817.
  40. Sahoo PK, Mukherjee SC, Nayak SK, Dey S (2001). Acute and subchronic toxicity of aflatoxin B1 to rohu, Labeo rohita (Hamilton). Indian J Exp Biol. 39(5): 453-8.
  41. Gursoy-Yuzugullu O, Yuzugullu H, Yilmaz M, Ozturk M (April 2011). "Aflatoxin genotoxicity is associated with a defective DNA damage response bypassing p53 activation". Liver International. 31 (4): 561–571. doi:10.1111/j.1478-3231.2011.02474.x. hdl: 11693/21978 . PMID   21382167. S2CID   18055477.
  42. Newberne PM, Wogan GN (April 1968). "Sequential morphologic changes in aflatoxin B carcinogenesis in the rat". Cancer Research. 28 (4): 770–781. PMID   4296938.
  43. Sur E, Celik I (September 2003). "Effects of aflatoxin B1 on the development of the bursa of Fabricius and blood lymphocyte acid phosphatase of the chicken". British Poultry Science. 44 (4): 558–566. doi:10.1080/00071660310001618352. PMID   14584846. S2CID   23402434.
  44. Wangikar PB, Dwivedi P, Sinha N, Sharma AK, Telang AG (April 2005). "Effects of aflatoxin B1 on embryo fetal development in rabbits". Food and Chemical Toxicology. 43 (4): 607–615. doi:10.1016/j.fct.2005.01.004. PMID   15721209.
  45. Sahoo PK, Mukherjee SC (2001). Immunosuppressive effects of aflatoxin B1 in Indian major carp (Labeo rohita). Comp Immunol Microbiol Infect Dis. 24(3):143-9.
  46. 1 2 "Aflatoxins". Archived from the original on 2017-07-06. Retrieved 2015-12-07.
  47. Rustom IY (1997). "Aflatoxin in food and feed: Occurrence, legislation and inactivation by physical methods". Food Chemistry. 59: 57–67. doi:10.1016/S0308-8146(96)00096-9.
  48. Park DL, Njapau H (1989). "Contamination issues, technology". Journal of the American Oil Chemists' Society. 66 (10): 1402–1405. doi:10.1007/BF02661958.
  49. Park DL, Liang B (October 1993). "Perspectives on aflatoxin control for human food and animal feed". Trends in Food Science & Technology. 4 (10): 334–342. doi:10.1016/0924-2244(93)90104-I.
  50. EEC (1991). EEC Council Directive 91/126/EEC. Amending the annexes to Council Directive 74/63/EEC on undesirable substances and products in animal nutrition. Off. J. Eur. Commun., No. L 60.
  51. FAO/WHO (1990). FAO/WHO Standards Programme. Codex Alimentarius Commission, Alinorm 91/29.
  52. FAO/WHO (1992). FAO/WHO Standards Programme. Codex Alimentarius Commission, Alinorm 93/12.
  53. Wannop CC (January 1961). "The Histopathology of Turkey "X" Disease in Great Britain". Avian Diseases. 5 (4): 371–381. doi:10.2307/1587768. JSTOR   1587768.
  54. Richard JL (January 2008). "Discovery of Aflatoxins and Significant Historical Features". Toxin Reviews. 27 (3–4): 171–201. doi:10.1080/15569540802462040. ISSN   1556-9543. S2CID   85650401.
  55. Ngindu A, Johnson BK, Kenya PR, Ngira JA, Ocheng DM, Nandwa H, et al. (June 1982). "Outbreak of acute hepatitis caused by aflatoxin poisoning in Kenya". Lancet. 1 (8285): 1346–1348. doi:10.1016/S0140-6736(82)92411-4. PMID   6123648. S2CID   36408376.